What medications, other than proton‑pump inhibitors (PPIs), are effective for treating epigastric pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications Other Than PPIs for Epigastric Pain

For epigastric pain, histamine-2 receptor antagonists (H2RAs) are the first alternative to PPIs, followed by tricyclic antidepressants (TCAs) as second-line therapy, with prokinetics as an additional option depending on symptom profile. 1

First-Line Alternatives to PPIs

Histamine-2 Receptor Antagonists (H2RAs)

H2RAs are an efficacious first-line treatment for functional dyspepsia and epigastric pain. These drugs are well tolerated and may provide symptomatic relief comparable to PPIs in some patients 1. While the evidence quality is lower than for PPIs (weak recommendation, low quality evidence), H2RAs represent a reasonable alternative when PPIs are contraindicated, not tolerated, or when patients prefer to avoid them.

Prokinetic Agents

Some prokinetics may be efficacious for epigastric pain, particularly when symptoms include early satiety or fullness 1. However, there are important caveats:

  • Efficacy varies significantly by drug class
  • Many prokinetics are unavailable outside Asia and the USA
  • Tegaserod has the strongest evidence (strong recommendation, moderate quality evidence)
  • Acotiamide, itopride, and mosapride have weaker evidence (weak recommendation, low quality evidence)
  • Most are well tolerated

Second-Line Treatment

Tricyclic Antidepressants (TCAs)

TCAs are the most strongly recommended second-line treatment for epigastric pain when first-line therapies fail (strong recommendation, moderate quality evidence) 1.

Specific dosing algorithm:

  • Start with amitriptyline 10 mg once daily at bedtime
  • Titrate slowly over weeks
  • Target dose: 30-50 mg once daily
  • Can be initiated in primary or secondary care

Critical counseling points:

  • Explain these are used as "gut-brain neuromodulators," NOT for depression
  • Discuss side effect profile upfront (anticholinergic effects: dry mouth, constipation, drowsiness)
  • Set realistic expectations about gradual onset of benefit

Antipsychotics

Antipsychotics may be efficacious as second-line treatment 1:

  • Sulpiride 100 mg four times daily, OR
  • Levosulpiride 25 mg three times daily

These require careful explanation of rationale and thorough counseling about side effects. Consider these only after TCAs have been tried or are contraindicated.

Treatment Algorithm for Epigastric Pain

After H. pylori testing and eradication (if positive):

  1. If PPIs are not an option or have failed:

    • Try H2RA (e.g., famotidine 20-40 mg twice daily)
    • If symptoms include early satiety/fullness, consider prokinetic (if available)
  2. If first-line alternatives fail:

    • Initiate TCA (amitriptyline 10 mg, titrate to 30-50 mg)
    • Allow 4-8 weeks for adequate trial
  3. If TCAs fail or are not tolerated:

    • Consider antipsychotic (sulpiride or levosulpiride)
    • Refer to gastroenterology for specialist management

Important Caveats

What to avoid:

  • Opioids should be avoided in functional dyspepsia/epigastric pain to minimize iatrogenic harm (strong recommendation) 1
  • Cisapride is no longer recommended due to cardiac toxicity 2

When to refer to gastroenterology:

  • Severe symptoms
  • Refractory to first-line treatments
  • Diagnostic uncertainty
  • Patient requests specialist opinion 1

Non-Pharmacological Approach

Regular aerobic exercise is strongly recommended for all patients with functional dyspepsia and epigastric pain (strong recommendation, though evidence quality is very low) 1. This should be advised alongside any pharmacological therapy.

The evidence for dietary therapies, including low-FODMAP diets, remains insufficient to make firm recommendations 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.